Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Lisa M. Barroilhet"'
Autor:
Erica V. Carballo, Katherine E. Maturen, Zhanhai Li, Krupa K. Patel-Lippmann, Ashish P. Wasnik, Elizabeth A. Sadowski, Lisa M. Barroilhet
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract IOTA (International Ovarian Tumor Analysis) Simple Rules classifies adnexal masses as benign, malignant, or indeterminate based on sonographic features. We seek to determine if IOTA inappropriately directed women to surgery, or more aggressi
Externí odkaz:
https://doaj.org/article/9a0b12028bf9424b8d3a2cfafbd62345
Autor:
Ticiana A. Leal, Marina N. Sharifi, Nancy Chan, Robert Wesolowski, Anita A. Turk, Justine Y. Bruce, Ruth M. O'Regan, Jens Eickhoff, Lisa M. Barroilhet, Jyoti Malhotra, Janice Mehnert, Eugenia Girda, Elizabeth Wiley, Natalie Schmitz, Shannon Andrews, Glenn Liu, Kari B. Wisinski
Publikováno v:
Cancer Medicine, Vol 11, Iss 21, Pp 3969-3981 (2022)
Abstract Background Inhibitors of poly(ADP‐ribose) polymerase (PARP) proteins potentiate antitumor activity of platinum chemotherapy. This study sought to determine the safety and tolerability of PARP inhibitor talazoparib with carboplatin and pacl
Externí odkaz:
https://doaj.org/article/d110893465fc4eceb9dd0c7b44d3c53f
Autor:
Rebecca Arend, Jhalak Dholakia, Cesar Castro, Ursula Matulonis, Erika Hamilton, Camille Gunderson Jackson, Kristopher LyBarger, Howard M. Goodman, Linda R. Duska, Haider Mahdi, Adam C. ElNaggar, Michael H. Kagey, Amy Liu, Diane Piper, Lisa M. Barroilhet, William Bradley, Jasgit Sachdev, Cynthia A. Sirard, David M. O'Malley, Michael Birrer
Publikováno v:
Gynecologic Oncology. 172:82-91
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3119dea5b8a715375b4afd1711f2bd14
https://doi.org/10.1016/j.ygyno.2023.03.013
https://doi.org/10.1016/j.ygyno.2023.03.013
Publikováno v:
Cancer. 128:2853-2857
Endometrial carcinoma (EC) classification and risk stratification have undergone a global transformation in the last decade, shifting from a reliance on poorly reproducible histomorphological parameters such as grade and histotype, toward a molecular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3566e82a6269497435228cd931d93f6e
https://doi.org/10.1002/cncr.34328
https://doi.org/10.1002/cncr.34328
Autor:
Elizabeth A. Sadowski, Andrea Rockall, Isabelle Thomassin-Naggara, Lisa M. Barroilhet, Sumer K. Wallace, Priyanka Jha, Akshya Gupta, Atul B. Shinagare, Yang Guo, Caroline Reinhold
Publikováno v:
Radiology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc152d3ee1f40de46450b3a73f774de8
https://doi.org/10.1148/radiol.223281
https://doi.org/10.1148/radiol.223281
Autor:
Ticiana A. Leal, Marina N. Sharifi, Nancy Chan, Robert Wesolowski, Anita A. Turk, Justine Y. Bruce, Ruth M. O'Regan, Jens Eickhoff, Lisa M. Barroilhet, Jyoti Malhotra, Janice Mehnert, Eugenia Girda, Elizabeth Wiley, Natalie Schmitz, Shannon Andrews, Glenn Liu, Kari B. Wisinski
Publikováno v:
Cancer Medicine. 11:3969-3981
Inhibitors of poly(ADP-ribose) polymerase (PARP) proteins potentiate antitumor activity of platinum chemotherapy. This study sought to determine the safety and tolerability of PARP inhibitor talazoparib with carboplatin and paclitaxel.We conducted a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f8fe232f34918a2fbaef210441f5aa4
https://doi.org/10.1002/cam4.4724
https://doi.org/10.1002/cam4.4724
Autor:
Nicha Boonpattrawong, Sejal Sharma, Rob Schultz, Mayra A. Betancourt Ponce, Lisa M. Barroilhet, Manish Patankar
Publikováno v:
Cancer Research. 83:4907-4907
Atovaquone (ATO) is an FDA-approved anti-malarial drug, which has also shown potent anti-cancer effects. We have previously demonstrated ATO as an effective chemotherapy against high-grade serous ovarian cancer in cell lines and mouse model. In the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd68c92f1fa5ead8dad4fd9b4aeb81f1
https://doi.org/10.1158/1538-7445.am2023-4907
https://doi.org/10.1158/1538-7445.am2023-4907
Autor:
Sejal T. Sharma, Liping Feng, Nicha Boonpattrawong, Lisa M. Barroilhet, Manish Patankar, Spencer S. Ericksen
Publikováno v:
Cancer Research. 83:5341-5341
High Grade Serous Ovarian Cancer (HGSOC) is a fatal disease that is typically detected at an advanced stage when there are limited modalities for effective treatment. Treatment efficacy against cancer is dependent on tumor metabolism and its adaptati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5f3146a7fc93fdc4e7b00a736ddc218
https://doi.org/10.1158/1538-7445.am2023-5341
https://doi.org/10.1158/1538-7445.am2023-5341
Autor:
Arvinder Kapur, Pooja Mehta, Aaron D Simmons, Spencer S. Ericksen, Geeta Mehta, Sean P. Palecek, Mildred Felder, Zach Stenerson, Amruta Nayak, Jose Maria Ayuso Dominguez, Manish Patankar, Lisa M. Barroilhet
Publikováno v:
Cancers; Volume 14; Issue 9; Pages: 2297
Oxidative phosphorylation is an active metabolic pathway in cancer. Atovaquone is an oral medication that inhibits oxidative phosphorylation and is FDA-approved for the treatment of malaria. We investigated its potential anti-cancer properties by mea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75e2564ca0940eec3e5900df08a74b08
https://doi.org/10.3390/cancers14092297
https://doi.org/10.3390/cancers14092297
Autor:
Michael Birrer, Cynthia Sirard, David O'Malley, Jasgit Sachdev, William Bradley, Lisa M Barroilhet, Girish S Naik, Michael Kagey, Haider Mahdi, Linda Duska, Howard goodman, kristopher S LyBarger, Camille Gunderson, Erika Hamilton, Ursula Matulonis, Cesar Castro, Adam Elnaggar, Rebecca Arend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4e1f31894042c7f9cccdd586ae3779e
https://doi.org/10.26226/morressier.5d2ee8e71e09a6f49485a8db
https://doi.org/10.26226/morressier.5d2ee8e71e09a6f49485a8db
